BOLD
Income statement / Annual
Last year (2023), Boundless Bio, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Boundless Bio, Inc. Common Stock's net income was -$49.43 M.
See Boundless Bio, Inc. Common Stock’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$957,000.00 |
$942,000.00 |
$682,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$957,000.00 |
-$942,000.00 |
-$682,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$41.68 M
|
$37.16 M
|
$19.28 M
|
$104.37 M
|
$75.90 M
|
$48.77 M
|
| General & Administrative
Expenses |
$12.16 M
|
$9.31 M
|
$6.02 M
|
$30.00 M
|
$17.28 M
|
$11.28 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$12.16 M
|
$9.31 M
|
$6.02 M
|
$30.00 M
|
$17.28 M
|
$11.28 M
|
| Other Expenses |
$0.00 |
-$100,000.00 |
-$5,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$54.80 M |
$46.47 M |
$25.30 M |
$134.37 M |
$93.18 M |
$60.05 M |
| Cost And Expenses |
$54.80 M |
$46.47 M |
$25.30 M |
$134.37 M |
$93.18 M |
$60.05 M |
| Interest Income |
$5.28 M |
$668,000.00 |
$96,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$957,000.00
|
$942,000.00
|
$682,000.00
|
$7.46 M
|
$3.75 M
|
$1.58 M
|
| EBITDA |
-$48.48 M
|
-$45.53 M
|
-$24.62 M
|
-$121.37 M
|
-$88.74 M
|
-$58.09 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$5.36 M
|
$568,000.00
|
$91,000.00
|
$5.55 M
|
$693,000.00
|
$378,000.00
|
| Income Before Tax |
-$49.43 M |
-$45.90 M |
-$25.21 M |
-$128.82 M |
-$92.48 M |
-$59.67 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$668,000.00 |
-$96,000.00 |
$5.55 M |
-$2.25 M |
$378,000.00 |
| Net Income |
-$49.43 M |
-$45.90 M |
-$25.21 M |
-$128.82 M |
-$90.24 M |
-$59.67 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-2.22 |
-2.06 |
-1.13 |
-2.93 |
-2.05 |
-1.36 |
| EPS Diluted |
-2.22 |
-2.06 |
-1.13 |
-2.93 |
-3.4 |
-5.59 |
| Weighted Average Shares
Out |
$22.24 M
|
$22.24 M
|
$22.24 M
|
$44.03 M
|
$44.03 M
|
$44.03 M
|
| Weighted Average Shares
Out Diluted |
$22.24 M
|
$22.24 M
|
$22.24 M
|
$44.03 M
|
$26.58 M
|
$10.67 M
|
| Link |
|
|
|
|
|
|
